Promus Capital’s ResMed RMD Stock Holding History

Promus Capital’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$137K	Hold	500	–	–	0.09%	96
2025 Q2	$129K	Hold	500	–	–	0.08%	96
2025 Q1	$112K	Sell	500 -8	-2%	-$1.87K	0.08%	101
2024 Q4	$116K	Buy	+508	New	+$122K	0.09%	98

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Promus Capital's RMD Position: Q3 2025 in Review

Promus Capital held its ResMed (RMD) position steady in Q3 2025 at 500 shares worth $137K. The position accounts for 0.09% of the portfolio, ranked #96.

Promus Capital first reported a position in RMD in Q4 2024 and has held it in 4 quarters since. 949 funds tracked by Wall St. Rank hold RMD as of Q3 2025.

Promus Capital held 500 shares of ResMed worth $137K as of Q3 2025.
Promus Capital left its ResMed share count unchanged in Q3 2025.
ResMed made up 0.09% of Promus Capital's portfolio in Q3 2025, its #96 holding.
Promus Capital first reported a position in ResMed in Q4 2024 and has held it in 4 quarters since.
949 funds tracked by Wall St. Rank held ResMed as of Q3 2025.

Based on Promus Capital's 13F filing for Q3 2025, filed 13 Nov 2025.